News & Articles

Study suggests our organs may have their own sexual identity

The key to fighting cancer in many cases is early detection, and earlier detection at the cellular level could mean survival for many cancer patients

Crown Bioscience to Commercialize University of York's Prostate Cancer Models for Drug Development

Sophia Genetics announces a strategic partnership with Integrated DNA Technologies to accelerate the adoption of next generation sequencing (NGS) in routine clinical diagnostics.

Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening

Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy

Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions

Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer

Alliance Combines the Power of Precise Single-Cell Isolation with Next Generation Sequencing

Bosch Packaging Technology Extended Range of Pharma Solid Seminars: Practical Trainings On Solid Pharmaceuticals

Approval enables European HLA laboratories and those beyond Europe requiring CE mark to adopt differentiated Next Generation Sequencing (NGS) solution for HLA typing

Latest update of industry manual for development of high-throughput screening assays calls on scientists from leading 3D cell culture provider for standardized viability, toxicity protocols.

FDA centers and researchers gain access to QIAGEN’s enhanced solutions for applications including microbial and microbiome analysis

Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China

SEAL Analytical Focuses On Reliable High-Throughput Analysis

The New Shimadzu Application Hand¬book “Clinical”

Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection

Liquid biopsy test delivers high negative predictive value of 99.2% for bladder cancer

Rigaku will be in attendance at 60th Biophysical Society Meeting Saturday, February 27, 2016 to Wednesday, March 2, 2016 Los Angeles, CA, presenting their single crystal and SAXS products at Booth #828

Scientifica Launches First US Office